Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering DSSTox_CID_3325.

Client Email

Product

DSSTox_CID_3325
HEALTH CANADA PATENTS

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

DSSTox_CID_3325

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 21 USDMF, 15 CEP/COS, 9 JDMF, 10 EU WC, 10 KDMF, 12 NDC API, 19 Listed Suppliers, $ API Reference Price

39 API Suppliers
21 USDMF
15 CEP/COS
9 JDMF
10 EU WC
10 KDMF
12 NDC API
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

18 API Suppliers

18 API Suppliers

FINISHED DOSAGE FORMULATIONS

415 FDF Dossiers, 72 FDA Orange Book, 244 Europe, 34 Canada, 21 Australia, 22 South Africa, 22 Listed Dossiers

415 FDF Dossiers
72 FDA Orange Book
244 Europe
34 Canada
21 Australia
22 South Africa
22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 15MG, TABLET;ORAL - 30MG, TABLET;ORAL - 45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 15MG, TABLET, ORALLY DISINTEGRATING;ORAL - 30MG, TABLET, ORALLY DISINTEGRATING;ORAL - 45MG

TABLET;ORAL - 15MG
TABLET;ORAL - 30MG
TABLET;ORAL - 45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, ORALLY DISINTEGRATING;ORAL - 15MG
TABLET, ORALLY DISINTEGRATING;ORAL - 30MG
TABLET, ORALLY DISINTEGRATING;ORAL - 45MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 4 Rochem International Inc, 19 SPI Pharma, 2 Seqens, 4 DKSH, 3 Jai Radhe Sales, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 13 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 2 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 29 BASF, 1 Clariant, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 49 Direct Compression, 37 Disintegrants & Superdisintegrants, 30 Controlled & Modified Release, 30 Granulation, 29 Thickeners and Stabilizers, 27 Taste Masking, 27 Solubilizers, 22 Chewable & Orodispersible Aids, 21 Lubricants & Glidants, 21 Co-Processed Excipients, 16 Parenteral, 15 Film Formers & Plasticizers, 14 Topical, 8 API Stability Enhancers, 7 Emulsifying Agents, 5 Empty Capsules, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

96 Fillers, Diluents & Binders
51 Coating Systems & Additives
49 Direct Compression
37 Disintegrants & Superdisintegrants
30 Controlled & Modified Release
30 Granulation
29 Thickeners and Stabilizers
27 Taste Masking
27 Solubilizers
22 Chewable & Orodispersible Aids
21 Lubricants & Glidants
21 Co-Processed Excipients
16 Parenteral
15 Film Formers & Plasticizers
14 Topical
8 API Stability Enhancers
7 Emulsifying Agents
5 Empty Capsules
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 13 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
13 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 226 Finished Drug Prices, 2 Annual Reports

2 US Medicaid Prescriptions
226 Finished Drug Prices
2 Annual Reports

MARKET PLACE

13 APIs, 2 FDF Dossiers

13 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 7 Others

2 EDQM
4 USP
7 Others

$ API Ref.Price (USD/KG) : 362 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Merck Canada Inc.

filter Patent Reset all filters

3 All

01 32386547

filter Product Reset all filters

3 All

01 3Mirtazapine

filter Dosage Reset all filters

3 All

01 3Tablet

filter Exp Date Reset all filters

3 All

01 32020-10-09

Product Main Page

01

Merck Canada Inc.

Mirtazapine

Formnext Forum

Not Confirmed

Merck Canada Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-10-09

Date Granted : 2010-06-08

Mirtazapine

Brand Name : REMERON RD

Patent Number : 2386547

Filing Date : 2000-10-09

Strength per Unit : 15 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-10-09

Date Granted : 2010-06-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Merck Canada Inc.

Mirtazapine

Formnext Forum

Not Confirmed

Merck Canada Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-10-09

Date Granted : 2010-06-08

Mirtazapine

Brand Name : REMERON RD

Patent Number : 2386547

Filing Date : 2000-10-09

Strength per Unit : 30 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-10-09

Date Granted : 2010-06-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Merck Canada Inc.

Mirtazapine

Formnext Forum

Not Confirmed

Merck Canada Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-10-09

Date Granted : 2010-06-08

Mirtazapine

Brand Name : REMERON RD

Patent Number : 2386547

Filing Date : 2000-10-09

Strength per Unit : 45 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-10-09

Date Granted : 2010-06-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?